These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31407195)

  • 21. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial.
    Mohammadianinejad SE; Majdinasab N; Sajedi SA; Abdollahi F; Moqaddam MM; Sadr F
    Clin Neuropharmacol; 2014; 37(3):73-8. PubMed ID: 24824661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
    Feigin VL; Doronin BM; Popova TF; Gribatcheva EV; Tchervov DV
    Eur J Neurol; 2001 Jan; 8(1):81-5. PubMed ID: 11509086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
    Goldstein LB; Lennihan L; Rabadi MJ; Good DC; Reding MJ; Dromerick AW; Samsa GP; Pura J
    JAMA Neurol; 2018 Dec; 75(12):1494-1501. PubMed ID: 30167675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin supplementation may benefit patients with acute ischemic stroke not eligible for reperfusion therapies: Results of a pilot study.
    Mehrpooya M; Mazdeh M; Rahmani E; Khazaie M; Ahmadimoghaddam D
    J Clin Neurosci; 2022 Dec; 106():66-75. PubMed ID: 36270095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.
    England TJ; Hedstrom A; O'Sullivan S; Donnelly R; Barrett DA; Sarmad S; Sprigg N; Bath PM
    Stroke; 2017 May; 48(5):1412-1415. PubMed ID: 28265014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial.
    Culp WC; Onteddu SS; Brown A; Nalleballe K; Sharma R; Skinner RD; Witt T; Roberson PK; Marsh JD
    J Vasc Interv Radiol; 2019 Aug; 30(8):1244-1250.e1. PubMed ID: 31349978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
    Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
    Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial.
    Savadi Oskouie D; Sharifipour E; Sadeghi Bazargani H; Hashemilar M; Nikanfar M; Ghazanfari Amlashi S; Abbaszade Z; Sadeghihokmabadi E; Rikhtegar R; Golzari SEJ
    Neurorehabil Neural Repair; 2017 Jul; 31(7):638-647. PubMed ID: 28454498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
    Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
    CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
    Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
    Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis.
    Wahlgren N; Thorén M; Höjeberg B; Käll TB; Laska AC; Sjöstrand C; Höijer J; Almqvist H; Holmin S; Lilja A; Fredriksson L; Lawrence D; Eriksson U; Ahmed N
    J Intern Med; 2017 Mar; 281(3):273-283. PubMed ID: 27862464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke.
    Urfer R; Moebius HJ; Skoloudik D; Santamarina E; Sato W; Mita S; Muir KW;
    Stroke; 2014 Nov; 45(11):3304-10. PubMed ID: 25270629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
    Chamorro A; Amaro S; Castellanos M; Segura T; Arenillas J; Martí-Fábregas J; Gállego J; Krupinski J; Gomis M; Cánovas D; Carné X; Deulofeu R; Román LS; Oleaga L; Torres F; Planas AM;
    Lancet Neurol; 2014 May; 13(5):453-60. PubMed ID: 24703208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
    Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
    Trials; 2015 Dec; 16():561. PubMed ID: 26654631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.